TABLE 3.
Youth Age Group, ya | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3–8 | 9–11 | 12–14 | 15–17 | 18+ | |||||||||||
n Out of Nb | % | RR (95% CI) | n Out of Nb | % | RR (95% CI) | n Out of Nb | % | RR (95% CI) | n Out of Nb | % | RR (95% CI) | n Out of Nb | % | RR (95% CI) | |
Non–HDL-C | |||||||||||||||
Normal | 117 out of 633 | 18.5 | Reference | 54 out of 392 | 13.8 | Reference | 77 out of 627 | 12.3 | Reference | 47 out of 342 | 13.7 | Reference | 7 out of 104 | 6.7 | Reference |
Elevated | 45 out of 371 | 12.1 | 0.89 (0.63–1.24) | 28 out of 238 | 11.8 | 0.95 (0.61–1.49) | 31 out of 240 | 12.9 | 1.27 (0.83–1.95) | 25 out of 191 | 13.1 | 1.11 (0.70–1.75) | 19 out of 119 | 16.0 | 2.43 (1.10–5.38)c |
Dyslipidemia | 68 out of 477 | 14.3 | 1.10 (0.80–1.52) | 45 out of 280 | 16.1 | 1.42 (0.92–2.20) | 34 out of 263 | 12.9 | 1.36 (0.91–2.03) | 32 out of 177 | 18.1 | 1.72 (1.08–2.72)c | 18 out of 130 | 13.9 | 2.20 (0.98–4.94) |
LDL-C | |||||||||||||||
Normal | 116 out of 629 | 18.4 | Reference | 56 out of 398 | 14.1 | Reference | 86 out of 673 | 12.8 | Reference | 49 out of 359 | 13.7 | Reference | 10 out of 119 | 8.4 | Reference |
Elevated | 34 out of 296 | 11.5 | 0.84 (0.59–1.21) | 25 out of 188 | 13.3 | 1.05 (0.66–1.67) | 21 out of 190 | 11.1 | 1.04 (0.65–1.66) | 20 out of 169 | 11.8 | 1.08 (0.66–1.77) | 19 out of 102 | 18.6 | 2.25 (1.12–4.55)c |
Dyslipidemia | 80 out of 556 | 14.4 | 1.15 (0.85–1.57) | 46 out of 324 | 14.2 | 1.24 (0.80–1.92) | 35 out of 267 | 13.1 | 1.35 (0.90–2.03) | 35 out of 182 | 19.2 | 1.97 (1.24–3.15)c | 15 out of 132 | 11.4 | 1.40 (0.66–2.99) |
All analyses were adjusted for age, BMI, and systolic blood pressure at baseline, sex, cohort, and length of follow-up.
The age when non–HDL-C or LDL-C levels were first measured in youth.
Number of participants with high IMT out of all participants.
Statistical significance, P < .05.